
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1150 | 1150 | 1158 | 1006 | 1201 | - |
Fund Return | 15.01% | 15.01% | 15.76% | 0.22% | 3.73% | - |
Place in category | 46 | 46 | 17 | 10 | 13 | - |
% in Category | 22 | 22 | 9 | 9 | 29 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fullgoal Tianhui Selected Growth Mi | 25.66B | 3.56 | -3.92 | 5.67 | ||
Fullgoal CSI 300 Strengthen Fund | 10.13B | -0.76 | -1.28 | 4.24 | ||
Fullgoal China Securities 500 Index | 7.32B | 1.08 | -0.99 | 3.22 | ||
Fullgoal China Secs new energy veh | 7.01B | 6.37 | -12.64 | 2.23 | ||
Fullgoal Tianding China Securities | 6.21B | -2.37 | 3.68 | 6.70 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhongou Medical and Health Hybrid A | 32.09B | 2.37 | -15.41 | - | ||
Zhongou Medical and Health Hybrid C | 32.09B | 2.17 | -16.08 | - | ||
E Healthcare Secotor | 5.01B | 8.80 | 2.68 | 6.77 | ||
China Universal Healthcare Serv mix | 3.92B | 15.20 | -7.23 | - | ||
BOC Innovative Health Care Alloc | 3.01B | 27.82 | 2.83 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
APT Medical | CNE100004C45 | 9.77 | 431.48 | -0.35% | |
Jiangsu Hengrui | CNE0000014W7 | 8.97 | 48.38 | -0.25% | |
Sichuan Biokin Pharmaceutical | CNE100006FN4 | 8.95 | 244.20 | +1.52% | |
Xizang Haisco Pharmaceutical A | CNE100001BC7 | 8.85 | 47.45 | +9.99% | |
Kelun Pharm A | CNE100000PW7 | 8.72 | 35.68 | +3.27% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review